EP3539551
AÐFERÐ VIÐ AÐ MEÐHÖNDLA RASKANIR Í TENGSLUM VIÐ MELANOCORTIN-4 VIÐTAKA Í ARFBLENDNUM ARFBERUM
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.12.2012EP published:
6.10.2021EP application number:
19158126.3
EP translation filed:
3.11.2021Grant published:
15.12.2021EPO information:
European Patent Register
Max expiry date:
27.12.2032Expiry date:
27.12.2026Next due date:
31.12.2026
Title:
METHOD OF TREATING MELANOCORTIN-4 RECEPTOR-ASSOCIATED DISORDERS IN HETEROZYGOUS CARRIERS
Timeline
Today
28.12.2012EP application
6.10.2021EP Publication
3.11.2021Translation submitted
15.12.2021Registration published
27.12.2026Expires
Owner
Name:
Rhythm Pharmaceuticals, Inc.Address:
222 Berkeley Street, 12th floor, 02116, Boston, MA, US
Inventor
Name:
TARTAGLIA, Louis, A.Address:
Newton, MA 02459, US
Name:
HENDERSON, BartAddress:
Belmont, MA 02478, US
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201161581391 PDate:
29.12.2011Country:
US
Classification
Categories:
A61K 38/00, C07K 14/72, A61K 38/08, A61K 38/04
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 23.11.2021
Expires: 27.12.2022
Payer: Tego IP ehf.
Number: 11
Paid: 15.1.2023
Expires: 27.12.2023
Payer: Árnason Faktor ehf.
Number: 12
Paid: 15.12.2023
Expires: 27.12.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 15.12.2023
Expires: 27.12.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 10.12.2024
Expires: 27.12.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 19.12.2025
Expires: 27.12.2026
Payer: Árnason Faktor ehf.